Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

CRISPR Therapeutics AG Filed Acc 0000940594-26-000069

Stakes reported in this filing

Reporting person Shares Of the class
ORBIS INVESTMENT MANAGEMENT LTD 4,501,782 4.7%
Allan Gray Australia Pty Ltd 17,479 0%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…